• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Amarin Corp PLC

+ Add to Watchlist

AMRN:US

1.7900 USD 0.0300 1.65%

As of 20:10:00 ET on 08/21/2014.

Snapshot for Amarin Corp PLC (AMRN)

Open: 1.8200 Day's Range: 1.7900 - 1.8500 Volume: 1,340,924
Previous Close: 1.8200 52wk Range: 1.2800 - 7.4000 1-Yr Rtn: -69.40%

Stock Chart for AMRN

No chart data available.
  • AMRN:US 1.7900
  • 1D
  • 1M
  • 1Y
1.8200
Interactive AMRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0300
Est. EPS (USD) (12/2014) -0.5170
Est. PEG Ratio -
Market Cap (M USD) 311.70
Shares Outstanding (M) 174.13
30 Day Average Volume 2,377,212
Price/Book (mrq) -
Price/Sale (ttm) 10.9381
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMRN

Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.

John F TheroPresident/CEOJoseph T KennedySenior VP/Chief Compliance Ofcr/Secy/Gen Cnsl
Aaron D BergSenior VP:Marketing & SalesSteven B Ketchum "Steve"Senior VP/Pres:Rsch & Dev
More Company Profile & Key Executives for AMRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil